Koffiekamer « Terug naar discussie overzicht

Omega Diagnostics Group [ODX] - Ready to Launch the Rocket

454 Posts, Pagina: « 1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 19 20 21 22 23 » | Laatste
Whoopie
0
quote:

Mits schreef op 12 november 2020 22:37:

Ik heb wel flink verlies inmiddels hier zeg, toch heb ik nog steeds hoop dat dit wat kan worden. Wat jullie?
Beetje zelfde verhaal hier.
Deze week doen al men COVID aandelen het slecht, maar ik zie nog wel een opleving.
TheBiG
0
AbC-19TM: Response to Media

e note the recent press speculation around the UK-RTC AbC-19TM assay and its performance. We are grateful to the authors for providing access to their data in the BMJ paper which we have reviewed.

We believe the press articles and related BMJ report puts a spotlight on the different types of antibody testing available and what their applications are, and we very much welcome this.

Our AbC-19TM IgG lateral flow assay is targeted at IgG antibodies to the full spike protein of SARS-CoV-2 (COVID19) to indicate a measure of immune response (aligned with neutralizing antibodies) and differs from other antibody tests, some of which our assay has been compared against (incorrectly in our view). Assays measuring IgM and IgG to the nucleocapsid (as used in this study) may be useful to show previous infection but have no place in understanding the levels of immunity producing antibodies (this requires measurement of IgG to Spike) as generated naturally or via vaccination.

We do have some concerns with the BMJ research report and modelling methodology, and we provide details below. However, the Department for Health & Social Care (DHSC) reviewed in detail the Public Health England (PHE) report on the UK-RTC AbC-19TM assay prior to ordering kits and has provided the following statement:

“This report shows these tests are approved for use in surveillance studies, which is what they were purchased for.

“They were never intended for, and have never been issued for widespread public use and it is misleading and unnecessarily inflammatory to purposefully ignore this fact in the report.

“This robust evaluation was carried out by PHE at the Department’s request before any purchase was made, and PHE approved the test for use in surveillance studies.”

Our customer, DHSC, is satisfied with the performance of the test, as is the UK-RTC, and will continue to use and roll out the use of the product. Public Health England conducted an evaluation at the DHSC’s request, prior to DHSC purchasing the product and will continue to deploy the test for use in surveillance studies.

www.abingdonhealth.com/abc-19-respons...
TheBiG
0
2. An initial study2 performed at Ulster University used methods as defined by Medicines and Healthcare products Regulatory Agency (MHRA)3. Guidance from MHRA stipulated a target product profile should determine the sensitivity and specificity of antibody tests by using at least 200 samples confirmed as positive for antibodies and at least 200 samples confirmed as negative for antibodies to SARS-CoV-2. The Ulster study fulfilled this requirement and undertook a laboratory evaluation of AbC-19TM to detect SARS-CoV-2 IgG in a highly characterised cohort of known antibody positive and known antibody negative samples. This showed performance of the assay, in this well characterised known population, to give sensitivity of 97.9% and specificity of 100%.
mercurius-adept
0
UK noemt ODX oversold vanochtend:
dailybusinessgroup.co.uk/2020/11/db-l...

Pharmaceuticals analysts believe shares in testing firms such as Synairgen and Scottish firm Omega Diagnostics have been oversold on the back of the vaccine news from Pfizer and BioNTech.

“While the results are very promising, we believe there was a large over-reaction in the market in response to the news,” says Mark Brewer at Pharmiweb.com.

“It should not have been unexpected – we hoped for positive results from vaccine manufacturers this month, and we hope there is more to come, as AstraZeneca-Oxford University and Moderna are also due to announce initial results this month, and overall there are 11 vaccines in Phase III testing.

“However, these early results do not diminish the urgent need for COVID-19 treatments and testing, which will still be required for years to come. We consider the price falls to stocks such as Synairgen (-39%), Avacta (-36%), genedrive (-38%), Omega Diagnostics (-25%) and Open Orphan (-9%) to offer good buying opportunities.

“Even if a vaccine is perfectly effective, this will take years. Until then, the vast majority of the population will need to rely on treatments and testing for COVID-19.”

Omega is due to report half-year figures on 30 November.
Fluxx
0
Voor de laatste keer vandaag bijgekocht. Mijn GAK staat inmiddels op 65 GBX.

Zit er met meer in dan ik zou willen. Maar verwacht toch echt wel een renounce in de komende weken. Bij koers van 80GBX vliegt de helft er weer uit.
TheBiG
0
Nou dit is toch wel goed nieuws!

The UK-RTC, a consortium of four Lateral Flow test manufacturers, of which CIGA Healthcare is a member, has today released an overview of the use of its AbC-19 test as a companion to the Oxford/AstraZeneca Vaccine.

"Almost 3 billion Oxford AstraZeneca Vaccines have been pre-ordered. It is expected the demand for the UK-RTC AbC-19 Rapid Tests will far exceed this number as repeat testing will be necessary to insure ongoing resistance.”

twitter.com/cigahealthcare/status/132...
TheBiG
0
quote:

TheBiG schreef op 13 november 2020 14:19:

Nou dit is toch wel goed nieuws!

The UK-RTC, a consortium of four Lateral Flow test manufacturers, of which CIGA Healthcare is a member, has today released an overview of the use of its AbC-19 test as a companion to the Oxford/AstraZeneca Vaccine.

"Almost 3 billion Oxford AstraZeneca Vaccines have been pre-ordered. It is expected the demand for the UK-RTC AbC-19 Rapid Tests will far exceed this number as repeat testing will be necessary to insure ongoing resistance.”

twitter.com/cigahealthcare/status/132...
UK RTC partner @cigahealthcare has published an overview of how the AbC-19 Rapid Test can be used alongside vaccine deployment @OmegaDiagnostic #ODX

twitter.com/WalbrookPR/status/1327244...
TheBiG
0
Omega Diagnostics bounces as UK RTC highlights rapid test as a companion to COVID-19 vaccines

Shares in Omega Diagnostics (AIM: ODX) soared by as much as 20 percent in the early afternoon after rapid test consortium partner CIGA Healthcare highlighted the use of the AbC-19 test as a companion to the Oxford/AstraZenenca vaccine.

The brief overview from CIGA highlights that the respective vaccine is designed to trigger the body to produce trimeric spike protein neutralising antibodies and the rapid AbC-19 test is designed to detect this.

The promising update also notes:

The AbC-19 test is approved for professional use and in trials for over-the-counter use.
It can also be used as a companion to other vaccines such as the one from Pfizer.
Almost 3 billion doses of the AztraZeneca vaccine have been ordered and it expects demand for its test to exceed this number across the globe. This is because it is likely people will have to be tested multiple times as the length of immunity will not be indefinite.
It also cryptically hit backs at recent tabloid criticism by highlighting over 98% sensitivity and specificity – including a quote from Sir John Bell that states “this rapid test appears to be truly amazing.”

The share price of ODX is currently at 55p.

www.sharebuyers.co.uk/shares/omega-di...
Wiz@rD
0
M c M
0
quote:

Fluxx schreef op 13 november 2020 09:18:

Voor de laatste keer vandaag bijgekocht. Mijn GAK staat inmiddels op 65 GBX.

Zit er met meer in dan ik zou willen. Maar verwacht toch echt wel een renounce in de komende weken. Bij koers van 80GBX vliegt de helft er weer uit.
Prima gezien Fluxx!
Zelfde verhaal hier, gak van 105p en toen hij vanochtend doordaalde tot 44p met duidelijke ontkrachtingen en geen aanleiding tot verdere daling toch maar wat bijgekocht. GAK nu 69p, moet wel een RNS van Omega overheen komen maar als die komt staan we volgende week weer boven de 100p m.i.
TheBiG
0
quote:

M c M schreef op 13 november 2020 15:44:

[...]

Prima gezien Fluxx!
Zelfde verhaal hier, gak van 105p en toen hij vanochtend doordaalde tot 44p met duidelijke ontkrachtingen en geen aanleiding tot verdere daling toch maar wat bijgekocht. GAK nu 69p, moet wel een RNS van Omega overheen komen maar als die komt staan we volgende week weer boven de 100p m.i.
Let op dat nu ook nieuws vanuit AstraZeneca over het vaccin invloed gaat hebben op de koers. Positief danwel negatief!
mercurius-adept
0
quote:

TheBiG schreef op 13 november 2020 14:19:

Nou dit is toch wel goed nieuws!

The UK-RTC, a consortium of four Lateral Flow test manufacturers, of which CIGA Healthcare is a member, has today released an overview of the use of its AbC-19 test as a companion to the Oxford/AstraZeneca Vaccine.

"Almost 3 billion Oxford AstraZeneca Vaccines have been pre-ordered. It is expected the demand for the UK-RTC AbC-19 Rapid Tests will far exceed this number as repeat testing will be necessary to insure ongoing resistance.”

twitter.com/cigahealthcare/status/132...
mooi gezien...toch wel 'swing van de dag ' zo: van 43p GBX -5% toen naar 57p +19% nu
Fluxx
0
Zondagavond. Tijd voor een analyse, mijn verwachting en een vleugje hoop.

Waar staan we?
Vrijdag 7 oktober tikten we de recordstand van 1,07 GBX aan. De belangrijkste reden was het begin van de tweede golf. Novacyt had gepiekt, en andere aandelen (ODX, GDR, ACVTA) gingen daarna mee.

Dinsdag 27 oktober, na publiceren van de jaarcijfers stort de koers van Omega verder in. Het aandeel dipt van 92 GBX naar 72 GBX. In tegenstelling tot Novacyt deelt het bedrijf geen grote winsten of verwachtingen.

Afgelopen maandag hakte het nieuws van Pfizer in als een bom. Het vaccin was wellicht dichterbij dan we dachten. Corona stocks kelderde 30 - 40% in waarde. ODX zakt van 76GBX naar 57GBX. Donderdag verschijnt er een pijnlijk artikel van de Guardian die ODX een flinke dreun geeft naar de 40 regionen.

ODX reageert op de Guardian en het nieuws van Pfizer. Het stuk uit de Guardian blijkt kant nog wel te slaan. De Engelse overheid is tevreden. En de komst van een vaccin van Astra Zeneca is juist positief voor de Engels anti-body variant. Want ze kunnen op grote schaal de testen met de vaccins meeleveren.

Vrijdag verandert het sentiment, en stijgt het terug naar 56GBX

Mijn verwachting
We gaan maandag verder stijgen. En mocht er al nieuws komen van Astra Zeneca, dan kan dit mogelijk een flinke versneller zijn terug naar de 100GBX regionen.

Mijn vleugje hoop
Zodra officiele bevestiging komt van grote orders / uk contract of AstraZeneca contract, kán dit aandeel door naar de 200-300GBX. Met uitzonderlijke potentie om zelfs de 500GBX nog te bereiken. Dit laatste, is wellicht meer hoop dan verwachting. Maar he, een mens moet kunnen dromen.

Alvast een fijne week toegewenst. En hopelijk staat de koers vrijdag op 100GBX.

Wiz@rD
0
AstraZeneca initial pre order of 3bn Covid-19 vaccines will be used with #ODX Antibody tests.
This is going global for this tiny company & play a very important role to fight against this virus.
We will be looking at many multiples upside..... THE NEXT COVID MULTIBAGGER!

Van op het novacyt forum
TheBiG
0
Dan hebben we ook nog de Mologic lateral flow test.
- CE mark
- Techinical transfer to ODX

ODX zal de test gaan produceren voor Mologic

twitter.com/NaPoM2021/status/13280635...
454 Posts, Pagina: « 1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 19 20 21 22 23 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
860,72  -4,64  -0,54%  15:36
 Germany40^ 17.737,90 -0,56%
 BEL 20 3.821,55 -0,13%
 Europe50^ 4.923,08 -0,27%
 US30^ 37.825,52 -0,49%
 Nasd100^ 17.294,43 -1,45%
 US500^ 5.003,20 -0,91%
 Japan225^ 37.523,47 -1,26%
 Gold spot 2.384,20 +0,20%
 EUR/USD 1,0672 +0,27%
 WTI 82,23 +0,18%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

WDP +2,80%
EBUSCO HOLDING +2,67%
Heineken +1,77%
Pharming +1,73%
Vopak +1,52%

Dalers

VIVORYON THER... -3,62%
Fugro -2,98%
ADYEN NV -2,86%
AMG Critical ... -2,78%
FASTNED -2,71%

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront